IMC Chicago’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $63.7M | Sell |
181,000
-34,100
| -16% | -$12.2M | 0.02% | 423 |
|
|
2025
Q4 | $70.4M | Sell |
215,100
-104,200
| -33% | -$33.1M | 0.03% | 388 |
|
|
2025
Q3 | $90.1M | Buy |
319,300
+91,900
| +40% | +$26.7M | 0.03% | 297 |
|
|
2025
Q2 | $63.5M | Buy |
227,400
+57,700
| +34% | +$16.3M | 0.03% | 326 |
|
|
2025
Q1 | $52.9M | Sell |
169,700
-61,600
| -27% | -$18.2M | 0.03% | 315 |
|
|
2024
Q4 | $60.3M | Buy |
231,300
+40,800
| +21% | +$12.1M | 0.03% | 299 |
|
|
2024
Q3 | $61.4M | Sell |
190,500
-6,500
| -3% | -$2.13M | 0.03% | 263 |
|
|
2024
Q2 | $61.6M | Buy |
197,000
+20,200
| +11% | +$5.93M | 0.04% | 251 |
|
|
2024
Q1 | $50.3M | Buy |
176,800
+84,900
| +92% | +$24.8M | 0.03% | 249 |
|
|
2023
Q4 | $26.5M | Buy |
91,900
+500
| +0.5% | +$136K | 0.02% | 386 |
|
|
2023
Q3 | $24.6M | Sell |
91,400
-27,800
| -23% | -$6.94M | 0.02% | 327 |
|
|
2023
Q2 | $26.5M | Buy |
119,200
+19,000
| +19% | +$4.41M | 0.02% | 313 |
|
|
2023
Q1 | $24.2M | Buy |
100,200
+3,300
| +3% | +$810K | 0.03% | 294 |
|
|
2022
Q4 | $25.4M | Buy |
96,900
+16,400
| +20% | +$4.4M | 0.04% | 261 |
|
|
2022
Q3 | $18.1M | Sell |
80,500
-7,700
| -9% | -$1.87M | 0.02% | 310 |
|
|
2022
Q2 | $21.5M | Buy |
88,200
+31,500
| +56% | +$7.72M | 0.03% | 282 |
|
|
2022
Q1 | $13.7M | Buy |
56,700
+10,000
| +21% | +$2.3M | 0.01% | 408 |
|
|
2021
Q4 | $10.5M | Sell |
46,700
-31,500
| -40% | -$6.65M | 0.01% | 480 |
|
|
2021
Q3 | $16.6M | Buy |
78,200
+46,900
| +150% | +$10.8M | 0.02% | 391 |
|
|
2021
Q2 | $7.63M | Sell |
31,300
-16,800
| -35% | -$4.13M | 0.01% | 507 |
|
|
2021
Q1 | $12M | Sell |
48,100
-44,900
| -48% | -$10.7M | 0.02% | 401 |
|
|
2020
Q4 | $21.4M | Buy |
93,000
+44,400
| +91% | +$10.2M | 0.03% | 265 |
|
|
2020
Q3 | $12.4M | Buy |
48,600
+24,800
| +104% | +$6.14M | 0.02% | 282 |
|
|
2020
Q2 | $5.61M | Sell |
23,800
-10,400
| -30% | -$2.37M | 0.01% | 359 |
|
|
2020
Q1 | $6.93M | Sell |
34,200
-3,900
| -10% | -$852K | 0.01% | 263 |
|
|
2019
Q4 | $9.19M | Buy |
38,100
+9,400
| +33% | +$2.07M | 0.02% | 227 |
|
|
2019
Q3 | $5.55M | Sell |
28,700
-28,300
| -50% | -$5.43M | 0.02% | 268 |
|
|
2019
Q2 | $10.5M | Buy |
57,000
+27,200
| +91% | +$4.87M | 0.03% | 169 |
|
|
2019
Q1 | $5.66M | Buy |
29,800
+4,700
| +19% | +$898K | 0.02% | 224 |
|
|
2018
Q4 | $4.89M | Buy |
+25,100
| New | +$4.9M | 0.02% | 207 |
|
Other funds holding AMGN
VCM
VPM
IMC Chicago's AMGN Position: Q4 2024 in Review
IMC Chicago sold out of Amgen (AMGN) in Q4 2024, closing a stake of 11,946 shares — an estimated $3.54M sold.
IMC Chicago first reported a position in AMGN in Q3 2024 and held it in 1 quarter. The position peaked at $3.85M in Q3 2024. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.
- IMC Chicago reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
- IMC Chicago sold 11,946 Amgen shares in Q4 2024, an estimated $3.54M.
- IMC Chicago first reported a position in Amgen in Q3 2024 and held it in 1 quarter.
- IMC Chicago's Amgen position peaked at $3.85M in Q3 2024.
- 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.
Based on IMC Chicago's 13F filing for Q4 2024, filed 27 Jan 2025.